Iron sucrose-labeled human mesenchymal stem cells: in vitro multilineage capability and in vivo traceability in a lapine xenotransplantation model.
暂无分享,去创建一个
[1] J. Dobson,et al. An in vitro model of mesenchymal stem cell targeting using magnetic particle labelling , 2015, Journal of tissue engineering and regenerative medicine.
[2] D. Brat,et al. Cancer stem cell division: when the rules of asymmetry are broken. , 2015, Stem cells and development.
[3] G. Jenkin,et al. Mesenchymal stem cell tracking in the intervertebral disc. , 2015, World journal of stem cells.
[4] P. Parejiya,et al. Physicochemical and structural characterization of iron–sucrose formulations: a comparative study , 2014, Pharmaceutical development and technology.
[5] C. Brantsing,et al. Cell viability and chondrogenic differentiation capability of human mesenchymal stem cells after iron labeling with iron sucrose. , 2014, Stem cells and development.
[6] M. Dezawa,et al. Mesenchymal Stem Cells and Their Subpopulation, Pluripotent Muse Cells, in Basic Research and Regenerative Medicine , 2014, Anatomical record.
[7] A. E. El Haj,et al. Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells – a rheumatoid arthritis mouse model , 2013, Stem Cell Research & Therapy.
[8] A. Lindahl,et al. Similar cellular migration patterns from niches in intervertebral disc and in knee-joint regions detected by in situ labeling: an experimental study in the New Zealand white rabbit , 2013, Stem Cell Research & Therapy.
[9] D. Lane,et al. Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. , 2013, Antioxidants & redox signaling.
[10] Y. Qi,et al. The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy , 2013, Molecular Biology Reports.
[11] A. E. El Haj,et al. Orthopaedic applications of nanoparticle-based stem cell therapies , 2012, Stem Cell Research & Therapy.
[12] Ali S. Arbab,et al. Self-Assembling Nanocomplexes by combining Ferumoxytol, Heparin And Protamine For Cell Tracking by MRI , 2011, Nature Medicine.
[13] A. Lindahl,et al. Human Disk Cells from Degenerated Disks and Mesenchymal Stem Cells in Co-Culture Result in Increased Matrix Production , 2009, Cells Tissues Organs.
[14] Wei Liu,et al. Detection and quantification of magnetically labeled cells by cellular MRI. , 2009, European journal of radiology.
[15] A. Weinfeld,et al. Hemosiderin estimations and sideroblast counts in the differential diagnosis of iron deficiency and other anemias. , 2009, Acta medica Scandinavica.
[16] S. Koelling,et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. , 2009, Cell stem cell.
[17] Liu Yang,et al. In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. , 2008, Joint, bone, spine : revue du rhumatisme.
[18] A. Ho,et al. The Stromal Activity of Mesenchymal Stromal Cells , 2008, Transfusion Medicine and Hemotherapy.
[19] P. Wielopolski,et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. , 2008, Biochemical and biophysical research communications.
[20] Peter M Jakob,et al. Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. , 2008, Biomaterials.
[21] J. Knoblich,et al. Mechanisms of Asymmetric Stem Cell Division , 2008, Cell.
[22] Ø. Kolbjørnsen,et al. Calcification of intervertebral discs in the dachshund: a radiographic and histopathologic study of 20 dogs , 2007, Acta veterinaria Scandinavica.
[23] C. Brantsing,et al. Differentiation of human mesenchymal stem cells and articular chondrocytes: Analysis of chondrogenic potential and expression pattern of differentiation‐related transcription factors , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[24] J. Cangiano,et al. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[25] P. Ljungman,et al. Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] Jeff W M Bulte,et al. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis , 2004, NMR in biomedicine.
[27] F. Barry. Biology and clinical applications of mesenchymal stem cells. , 2003, Birth defects research. Part C, Embryo today : reviews.
[28] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] U. Bahner,et al. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] A I Caplan,et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. , 1998, Experimental cell research.
[31] S. Fowler,et al. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[32] R. Horobin,et al. Surface staining of cartilage by Alcian Blue, with reference to the role of microscopic dye aggregates in histological staining , 1974, The Histochemical Journal.
[33] J. Scott,et al. The chemical and histochemical properties of Alcian Blue , 1964, Histochemie.
[34] Wiendelt Steenbergen,et al. Evaluation of superparamagnetic iron oxide nanoparticles (Endorem®) as a photoacoustic contrast agent for intra-operative nodal staging. , 2013, Contrast media & molecular imaging.
[35] M. Kassem,et al. Human mesenchymal stem cells: from basic biology to clinical applications , 2008, Gene Therapy.
[36] P. Charbord,et al. Culture and characterization of human bone marrow mesenchymal stem cells. , 2007, Methods in molecular medicine.
[37] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[38] D. Jarocha,et al. Mesenchymal stem cells: characteristics and clinical applications. , 2006, Folia histochemica et cytobiologica.
[39] F. Marini,et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. , 2005, Cytotherapy.